What Is a GLP-1? How These Medications Work, in Plain Language

the short answer

GLP-1 is glucagon-like peptide-1, a hormone your gut releases after you eat. It tells your brain you are full, slows the stomach's emptying, and helps the pancreas release insulin. GLP-1 medications such as semaglutide and tirzepatide are longer-lasting copies of that hormone, taken as a once-weekly injection to lower appetite.

The name gets used three ways, which is where most of the confusion comes from. "GLP-1" is the hormone. "A GLP-1" is shorthand for a medication that copies it. And "GLP-1s" as a group includes tirzepatide, which copies GLP-1 plus a second gut hormone. This article covers all three, then what the medications do in practice, what the trials measured, how they are taken, what the first weeks are like, what happens when you stop, and who a physician will and will not prescribe them to.

what GLP-1 stands for, and what the hormone does

GLP-1 stands for glucagon-like peptide-1. The name comes from its chemistry: it is a peptide, a short chain of about 30 amino acids, and it was first identified because its structure resembles glucagon, another hormone involved in blood sugar. The two have opposite effects on blood sugar: glucagon raises it, and GLP-1 helps bring it down.

Cells in the lining of your small intestine release GLP-1 within minutes of food arriving.^[1] It then does three things at once. It signals the brain's appetite centers that a meal is underway, which is part of why you stop eating. It slows how fast the stomach empties into the intestine, so the meal is absorbed gradually and you feel full for longer. And it prompts the pancreas to release insulin in proportion to the sugar coming in, while reducing the release of glucagon.

Everyone makes GLP-1. It is one of several signals the body uses to match how much you eat to how much you need, and it is active at every meal whether or not you notice it.

why the hormone lasts minutes and the medication lasts a week

Natural GLP-1 is broken down by an enzyme in the blood within about two minutes of release.^[1] The signal rises with a meal and fades soon after, so the next meal can trigger it again.

A GLP-1 medication is a copy of the hormone with small changes to its structure that protect it from that enzyme and keep it bound to proteins in the blood. The result stays active for about a week instead of minutes, which is why the dose is a single injection every seven days. The receptor it fits, and the signal it sends, are the same as the hormone's. The difference is that the signal is steady all week rather than rising and falling with meals.

This is the same approach used for other peptide medications: take a signal the body already makes and modify it to last. What are peptides covers the general idea and where the GLP-1 medications fit among the others.

the two molecules: semaglutide and tirzepatide

Two GLP-1 medications are prescribed for weight in the U.S., and both are peptides given once a week.

Semaglutide is a modified copy of GLP-1 alone. It is the same molecule as Ozempic® and Wegovy®, and it is the one most people start with because it has the longest track record for weight.

Tirzepatide copies GLP-1 and a second gut hormone, GIP, which is also released after meals and works through its own receptor. It is the same molecule as Mounjaro® and Zepbound®. Activating both signals produced larger average weight loss in trials than semaglutide, which is covered below, and semaglutide vs tirzepatide compares the two directly.

Both are available as compounded medications, made to a physician's prescription by a licensed U.S. compounding pharmacy, which is how Pepvio prescribes them.

what they do in practice

The effect people notice is on appetite. Hunger between meals is lower. Fullness arrives sooner, often after a smaller portion than usual. And most people spend less time thinking about food between meals, with fewer cravings, especially for high-fat foods.

A study that measured this directly found that adults on semaglutide ate about 24 percent fewer calories at a free-choice meal than adults on placebo, reported less hunger and better control over eating, and had no change in resting metabolic rate once their lower body weight was accounted for.^[2] Weight comes off because people eat less without the effort that usually takes. Metabolic rate stays about where it was.

That is also why the habits around the medication matter. Eating less means eating less protein unless you plan for it, and a calorie deficit takes muscle along with fat unless resistance training gives the body a reason to keep it. How to increase your metabolism after 40 covers the muscle and protein side, which applies on a GLP-1 as much as off one.

what the trials showed

The trial that led to semaglutide's approval for weight, STEP 1, followed about 1,960 adults with obesity or overweight for 68 weeks. Those on semaglutide 2.4 mg lost an average of about 15 percent of body weight. Those on placebo, with the same diet and activity counseling, lost about 2 percent.^[3]

The equivalent tirzepatide trial, SURMOUNT-1, followed about 2,540 adults for 72 weeks. On the highest dose, 15 mg, the average loss was about 21 percent; on placebo it was about 3 percent.^[4]

The trial results are averages, and individual results vary. Some people lose more, some less, and a small share do not respond at all. The averages are useful for setting expectations: on either medication, most people lose a meaningful amount of weight over about a year, and the loss builds gradually rather than arriving in the first month.

how they are taken

Both medications are a once-weekly injection under the skin, usually into the abdomen or thigh, with a small insulin-style needle. Most people give it to themselves at home on the same day each week and describe the first one as the only hard one.

The dose starts low and steps up over several months, typically every four weeks, so the stomach has time to adjust before each increase. The starting dose is a fraction of the full dose. Your physician sets the schedule, holds a step longer if side effects are noticeable, and decides where the dose settles based on how you are responding. Reaching the full dose takes about four to five months on the standard schedule, which is why the trials ran over a year.

what the first weeks feel like

The first change most people notice, within the first week or two, is that they stop thinking about food as much. The first side effects show up around the same time. Nausea is the most common, followed by constipation, and both are most likely in the days after a dose increase and then fade as the body adjusts. Smaller meals, less fat, more water, and eating slowly reduce them for most people. Fatigue and some reflux are also common early on. Serious side effects are uncommon, and the intake questions and physician follow-up exist to catch the people at higher risk of them. GLP-1 side effects month by month walks through what to expect at each stage and when to call your physician.

what happens when you stop

The medication lowers appetite while it is in your system. When it leaves, appetite returns to where it was. The STEP 1 researchers followed participants for a year after the trial ended and the medication was withdrawn: on average, people regained about two-thirds of the weight they had lost.^[5]

For that reason, physicians treat a GLP-1 as ongoing care rather than a course with a fixed end date, the way blood pressure medication is treated. Some people stay on a maintenance dose long term. Some step down and hold. What makes the difference after stopping is what was built during treatment: the protein habit, the resistance training, and the muscle that came through the weight loss intact. Stopping or stepping down is a decision to plan with your physician rather than make on your own.

who it is for

A physician decides based on BMI and health history. The medications are prescribed for adults with obesity, or with overweight plus a weight-related condition such as high blood pressure, high cholesterol, or prediabetes. The intake asks about these directly.

Some conditions rule them out. They are not used during pregnancy or while trying to conceive. They are not prescribed to anyone with a personal or family history of medullary thyroid cancer or the genetic syndrome MEN 2, which is on the label for both molecules. A history of pancreatitis, certain stomach conditions, and some other medications also need a physician's review. This is what the online visit is for, and it is why the medication is prescription-only.

how Pepvio prescribes it

Pepvio prescribes compounded semaglutide and compounded tirzepatide. The online visit takes about 2 minutes and covers your health history, current medications, and goals. A licensed U.S. physician reviews it, and you are charged only after the physician approves. A licensed U.S. compounding pharmacy makes the medication to your prescription and ships it to you.

Pricing is dose-flat under the Price Lock: the price you start at is the price you pay as the dose steps up, and it does not increase in the second year. Every dose increase is at no extra cost. Doctor review and shipping are free, and you pay only for the medication. The GLP-1 page has the current plans for each molecule.

If you already know weight is what you want to address, the online visit below is the next step. If you are still deciding, the tirzepatide guide and GLP-1 side effects month by month cover the two questions people most often ask next.

---